Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial. Bhatt DL, Briggs AH, Reed SD, Annemans L, et al. J Am Coll Cardiol 2020;75:2297-2308.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bhatt DL, Briggs AH, Reed SD, Annemans L, et al. Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial. J Am Coll Cardiol 2020;75:2297-2308.
PMID: 32381160